Journal Watch
Thrombotic microangiopathies
Is eculizumab indicated in patients with atypical hemolytic uremic syndrome already on prolonged dialysis? A case report and review of the literature.
Author(s): Haskin O, Falush Y, Davidovits M Source: Pediatr Nephrol 2019 Sep 13; Publication date: 2019-09-13
New insights into the pathogenesis of Streptococcus pneumoniae-associated hemolytic uremic syndrome.
Author(s): Scobell RR, Kaplan BS, Copelovitch L Source: Pediatr Nephrol 2019 Sep 13; Publication date: 2019-09-13
Profiles of Coagulation and Fibrinolysis Activation-Associated Molecular Markers of Atypical Hemolytic Uremic Syndrome in the Acute Phase.
Author(s): Sakurai S, Kato H, Yoshida Y, Sugawara Y, Fujisawa M, Yasumoto A, Matsumoto M, Fujimura Y, Yatomi Y, Nangaku M Source: J Atheroscler Thromb 2019 Sep 4; Publication date: 2019-09-4
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
Author(s): Cavero T, Arjona E, Soto K, Caravaca-Fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-Gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M Source: Kidney Int 2019 May 31; Publication date: 2019-05-31
Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy.
Author(s): Zheng L, Zhang D, Cao W, Song W, Zheng XL Source: Blood 2019 Aug 13; Publication date: 2019-08-13 |
Thematic areasHereditary glomerulopathies Immune glomerulopathies Tubulopathies Metabolic and stone disorders Thrombotic microangiopathies AD structural kidney disorders Renal malformations and ciliopathies Obstructive nephropathies Pediatric CKD and dialysis Pediatric kidney transplantationRecently added publications |
